Darren S. Cline - Apr 12, 2023 Form 4 Insider Report for IMPEL PHARMACEUTICALS INC (IMPL)

Role
Director
Signature
/s/ Adrian Adams as attorney-in-fact
Stock symbol
IMPL
Transactions as of
Apr 12, 2023
Transactions value $
$0
Form type
4
Date filed
4/14/2023, 04:58 PM
Previous filing
Mar 28, 2023
Next filing
Jun 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMPL Stock Option (right to buy) Award $0 +20K $0.00 20K Apr 12, 2023 Common Stock 20K $1.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/3rd of the total shares on April 12, 2024 and then 1/36th of the total shares vests on each monthly anniversary thereafter, with 100% of the total shares vested and exercisable on April 12, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.